Pages that link to "Q40468601"
Jump to navigation
Jump to search
The following pages link to Selective recognition of oligomeric HIV-1 primary isolate envelope glycoproteins by potently neutralizing ligands requires efficient precursor cleavage. (Q40468601):
Displaying 50 items.
- Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus Macaques (Q27318508) (← links)
- Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies (Q27644515) (← links)
- Structural Basis of Immune Evasion at the Site of CD4 Attachment on HIV-1 gp120 (Q27658449) (← links)
- A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield (Q27675032) (← links)
- A gp41 MPER-specific Llama VHH Requires a Hydrophobic CDR3 for Neutralization but not for Antigen Recognition (Q27676864) (← links)
- Structural delineation of a quaternary, cleavage-dependent epitope at the gp41-gp120 interface on intact HIV-1 Env trimers (Q27683553) (← links)
- A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies (Q28299280) (← links)
- An efficiently cleaved HIV-1 clade C Env selectively binds to neutralizing antibodies (Q28545185) (← links)
- Functional stability of unliganded envelope glycoprotein spikes among isolates of human immunodeficiency virus type 1 (HIV-1) (Q28743199) (← links)
- Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target (Q29547347) (← links)
- Effect of trimerization motifs on quaternary structure, antigenicity, and immunogenicity of a noncleavable HIV-1 gp140 envelope glycoprotein (Q33571825) (← links)
- In-solution virus capture assay helps deconstruct heterogeneous antibody recognition of human immunodeficiency virus type 1 (Q33725718) (← links)
- Comparing antigenicity and immunogenicity of engineered gp120. (Q33984309) (← links)
- A novel, live-attenuated vesicular stomatitis virus vector displaying conformationally intact, functional HIV-1 envelope trimers that elicits potent cellular and humoral responses in mice (Q34172295) (← links)
- Subunit organization of the membrane-bound HIV-1 envelope glycoprotein trimer (Q34292319) (← links)
- Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1. (Q34434854) (← links)
- Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-gp120 interface (Q34473958) (← links)
- Glycosylation of the core of the HIV-1 envelope subunit protein gp120 is not required for native trimer formation or viral infectivity (Q34555891) (← links)
- Increased functional stability and homogeneity of viral envelope spikes through directed evolution (Q34611144) (← links)
- Chimeric HIV-1 envelope glycoproteins with potent intrinsic granulocyte-macrophage colony-stimulating factor (GM-CSF) activity (Q34658136) (← links)
- An HIV-1 envelope glycoprotein trimer with an embedded IL-21 domain activates human B cells (Q34796885) (← links)
- Stable, uncleaved HIV-1 envelope glycoprotein gp140 forms a tightly folded trimer with a native-like structure (Q34831341) (← links)
- HIV-1 envelope glycoprotein variable loops are indispensable for envelope structural integrity and virus entry (Q34924647) (← links)
- Structure-based Vaccine Design in HIV: Blind Men and the Elephant? (Q34987048) (← links)
- Binding interactions between soluble HIV envelope glycoproteins and quaternary-structure-specific monoclonal antibodies PG9 and PG16. (Q35077716) (← links)
- A native-like SOSIP.664 trimer based on an HIV-1 subtype B env gene (Q35110976) (← links)
- HIV Type 1 Env Precursor Cleavage State Affects Recognition by Both Neutralizing and Nonneutralizing gp41 Antibodies (Q35173635) (← links)
- Mechanism of Neutralization by the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01 (Q35192782) (← links)
- Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors (Q35382871) (← links)
- Well-ordered trimeric HIV-1 subtype B and C soluble spike mimetics generated by negative selection display native-like properties (Q35540033) (← links)
- Single-Chain Soluble BG505.SOSIP gp140 Trimers as Structural and Antigenic Mimics of Mature Closed HIV-1 Env. (Q35641498) (← links)
- The role of amino acid changes in the human immunodeficiency virus type 1 transmembrane domain in antibody binding and neutralization (Q35644971) (← links)
- Intraprotomer masking of third variable loop (V3) epitopes by the first and second variable loops (V1V2) within the native HIV-1 envelope glycoprotein trimer (Q35647772) (← links)
- PGV04, an HIV-1 gp120 CD4 binding site antibody, is broad and potent in neutralization but does not induce conformational changes characteristic of CD4. (Q35868102) (← links)
- A New Approach to Produce HIV-1 Envelope Trimers: BOTH CLEAVAGE AND PROPER GLYCOSYLATION ARE ESSENTIAL TO GENERATE AUTHENTIC TRIMERS (Q35925858) (← links)
- Antigenicity and immunogenicity of HIV-1 consensus subtype B envelope glycoproteins (Q35933555) (← links)
- Targeted Isolation of Antibodies Directed against Major Sites of SIV Env Vulnerability (Q35985519) (← links)
- Structure and Recognition of a Novel HIV-1 gp120-gp41 Interface Antibody that Caused MPER Exposure through Viral Escape. (Q36246403) (← links)
- Antigenic characterization of the human immunodeficiency virus (HIV-1) envelope glycoprotein precursor incorporated into nanodiscs (Q36267348) (← links)
- HIV-1 neutralizing antibodies display dual recognition of the primary and coreceptor binding sites and preferential binding to fully cleaved envelope glycoproteins (Q36276274) (← links)
- Mutations in envelope gp120 can impact proteolytic processing of the gp160 precursor and thereby affect neutralization sensitivity of human immunodeficiency virus type 1 pseudoviruses. (Q36315745) (← links)
- CD4 binding determinant mimicry for HIV vaccine design (Q36469664) (← links)
- Proteolytic processing of the human immunodeficiency virus envelope glycoprotein precursor decreases conformational flexibility (Q36559735) (← links)
- N-terminal substitutions in HIV-1 gp41 reduce the expression of non-trimeric envelope glycoproteins on the virus (Q36565090) (← links)
- Virus-like particles: designing an effective AIDS vaccine (Q36602273) (← links)
- Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C-Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in the V1 Loop (Q36694111) (← links)
- Native Conformation and Canonical Disulfide Bond Formation Are Interlinked Properties of HIV-1 Env Glycoproteins (Q36736597) (← links)
- Advances in methods for the production, purification, and characterization of HIV-1 Gag-Env pseudovirion vaccines. (Q36971140) (← links)
- Molecular architecture of the uncleaved HIV-1 envelope glycoprotein trimer (Q37049334) (← links)
- B cells from knock-in mice expressing broadly neutralizing HIV antibody b12 carry an innocuous B cell receptor responsive to HIV vaccine candidates (Q37171260) (← links)